Fairvalue-Calculator Fairvalue-Calculator
EN DE

Optima Health plc (OPT) Fair Value & Analysis

Healthcare · GB · Market cap 204M GBX

Pricep1.91
Fair Valuep0.5500
Upside-71.2%
Quality91/100
Evidence: High Range p0.3700 – p0.5500

Fair value as of: Jun 24, 2026

Analysis

Optima Health plc (OPT) currently trades at p1.91, while our model-based Fair Value estimate is p0.5500 — implying the stock looks roughly 71.2% overvalued today. We read business quality at 91/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Optima Health plc provides occupational health and wellbeing services for the public and private sectors in the United Kingdom. The company offers strategy and advisory services; risk and compliance services comprising health surveillance, pre-placement, fitness for work, immunizations, and pensions; performance and attendance services, including attendance and productivity management; engagement and wellbeing services through digital platforms, health assessments, and onsite activities; mental health services; and musculoskeletal health services. It serves the energy and utilities, construction, manufacturing, rail, transport, and financial sectors; and NHS, central, and local governments. The company was founded in 1947 and is headquartered in Sheffield, the United Kingdom.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Optima Health plc (OPT) undervalued?
As of Jun 24, 2026, our model estimates a fair value of p0.5500 versus a price of p1.91 — about −71% (overvalued). Model-based estimate, not financial advice.
What is the fair value of OPT?
Our 21-model fair value for Optima Health plc is p0.5500 (as of Jun 24, 2026), built from audited fundamentals. The current price is p1.91.
What is the quality score of OPT?
Optima Health plc has a Quality Score of 91/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.